Master student position (Translational Research)

Immunotherapy & Biotechnology: Validation of humanized Chimeric Antigen Receptors targeted against solid tumour

A Master position is available for 2021 at the Unit of Translational Research, Department of Cellular Therapy, Oslo University Hospital (OUS) Radiumhospitalet under the supervision of Sébastien Wälchli (Senior researcher, group leader).

We offer: (1) a position in a dynamic environment within a modern/fully equipped facility (Oslo Cancer Cluster Incubator next to Radium hospital) and (2) the possibility to use advanced technology.

Successful candidates might be sent to an international conference.

Find out more here !

Any questions about the position can be sent to the following e-mail address: sebastw@rr-research.no

 

Biomedical scientist position (Cell Therapy Products)

Main Tasks:  Preparation and processing of cell therapy products in classified clean rooms for use in patient treatment. This will include apheresis, quality work and processing of products in clean rooms after cell harvesting. It may be relevant that the person hired is part of a shift

Qualifications: The candidate must be a trained bioengineer. Experience with apheresis and work in clean rooms will be emphasized. Experience with methods such as flow cytometry, hematology machines and clonogenic assays will be emphasized. Good Norwegian skills Personal characteristics Flexibility Good collaboration skills Personal suitability and ability to work in teams will be emphasized. Applicants must be responsible, independent and thrive on interdisciplinary collaboration in an active and busy environment.

We offer: wages in accordance with agreement High professional level Challenging and varied work tasks Nice and social work environment Professional and personal developement.

Contact information: Section leader Dag Josefsen, mobile 95990328

Find out more here !

----------

For other opportunities, make sure to take a look at the OUS recruitment page!

 

 
Jul 29, 2016 Page visits: 549